Kawachi, Hayato
Tamiya, Motohiro http://orcid.org/0000-0001-6529-3092
Tamiya, Akihiro
Ishii, Seigo
Hirano, Katsuya
Matsumoto, Hirotaka
Fukuda, Yasushi
Yokoyama, Toshihide
Kominami, Ryota
Fujimoto, Daichi
Hosoya, Kazutaka
Suzuki, Hidekazu
Hirashima, Tomonori
Kanazu, Masaki
Sawa, Nobuhiko
Uchida, Junji
Morita, Mitsunori
Makio, Takeshi
Hara, Satoshi
Kumagai, Toru
Article History
Received: 15 November 2019
Accepted: 20 November 2019
First Online: 30 November 2019
Compliance with ethical standards
:
: Drs. Kawachi, Fujimoto, Motohiro Tamiya, Akihiro Tamiya, Hirano, and Kumagai have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan) and Merck Sharp & Dohme, Corp. (Tokyo, Japan). Drs. Yokoyama and Hirashima have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). Drs. Ishida and Kanazu have received lecture fees from Merck Sharp & Dohme, Corp. (Tokyo, Japan). All remaining authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later aemndments or comparable ethical standards. The study protocol was approved by the review board of each of the 11 institutions and this study was registered with UMIN (University Hospital Medical Information Network in Japan reference number 000032470).
: For this type of study, formal consent is not required.